A true partner in the pursuit of expanded healthspan

Our team of scientists and operational experts work closely across our pipeline programs, providing scientific and organizational support for a competitive edge in a rapidly-evolving field. Together, we are advancing breakthrough treatments for metabolic disease with the ultimate goal of preventing chronic illness before it takes hold.

Mission Statement

Who We Are
We are a dedicated team of scientists and business experts who share a common goal: to improve the quality of life for people all over the world. To do this, we are developing medicines that target the metabolic pathways that decline with age, first as treatments and then as preventive medicines.

Our Commitment
We are committed to creating a world where people can be physically and mentally healthy for their entire first century of life. We believe that everyone deserves to live a long, healthy, and fulfilling life, free from the burden of chronic metabolic disease.

Our Values

Big ideas, distilled to practice
Always have a hypothesis
Take bold, measured risks
Be brilliant together
Character matters

Our Values

  • Big Ideas, Distilled to Practice
  • Always Have a Hypothesis
  • Take Bold, Measured Risks
  • Be Brilliant Together
  • Character Matters
“Over the next 10 or 15 years, Cambrian wants to bring the way that we treat the diseases of aging into the 21st century by preventing them from happening, instead of waiting for people to get sick, the same way that we learned how to prevent and reverse the pathologies of infectious diseases like smallpox and polio in the 20th century.”

James Peyer

CEO and Founder of Cambrian Bio

Our Approach

Cambrian’s sourcing and development engine allows us to identify promising science, deploy capital and teams of drug development experts, and provide stewardship to advance new medicines that will lengthen healthspan. By leveraging established expertise and repeatable functional models, we achieve vast efficiencies in execution speed and resource utilization.

Cambrian’s hypothesis-driven approach and industry-leading portfolio of drug candidates provides for multiple “shots on goal” as we endeavor to discover breakthroughs to disrupt the biology of aging – first to treat disease, and ultimately to prevent it.

The Story

We combine scientific rigor with an audacious mission: developing transformative, effective and safe therapies to extend healthspan. A crucial aspect of our vision is making these therapies widely available, wherever possible.

Our PipeCos

Accessibility Icon